Megakaryoblast
|
WikiDoc Resources for Megakaryoblast |
|
Articles |
|---|
|
Most recent articles on Megakaryoblast Most cited articles on Megakaryoblast |
|
Media |
|
Powerpoint slides on Megakaryoblast |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Megakaryoblast at Clinical Trials.gov Trial results on Megakaryoblast Clinical Trials on Megakaryoblast at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Megakaryoblast NICE Guidance on Megakaryoblast
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Megakaryoblast Discussion groups on Megakaryoblast Patient Handouts on Megakaryoblast Directions to Hospitals Treating Megakaryoblast Risk calculators and risk factors for Megakaryoblast
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Megakaryoblast |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A megakaryoblast is a precursor cell to a promegakaryocyte, which in turn becomes a megakaryocyte. It is the beginning of the thrombocytic series.
It derives from an CFU-Me colony unit of pluripotential hemopoietic stem cells.
Additional images
-
Blood cell lineage
